Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Microhematuria--what next?].

P Bader1, M G Mohaupt

  • 1Urologische Klinik, Inselspital, Universität Bern, Schweiz.

Der Urologe. Ausg. A
|October 25, 2000
PubMed
Summary
This summary is machine-generated.

Asymptomatic microhematuria requires a standardized diagnostic approach. A new algorithm helps urologists identify serious conditions while avoiding unnecessary tests for microscopic blood in urine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of acute GvHD severity on survival and disease relapse in pediatric patients undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia: an analysis based on the EBMT-PDWP registry.

Bone marrow transplantation·2026
Same author

Interplay between acute graft-versus-host disease and graft-versus-leukemia effect in pediatric acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: implications for relapse incidence and survival - an EBMT PDWP retrospective study.

Bone marrow transplantation·2025
Same author

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Association study of candidate DNA-repair gene variants and acute graft versus host disease in pediatric patients receiving allogeneic hematopoietic stem-cell transplantation.

The pharmacogenomics journal·2021
Same author

Pregnancy and pregnancy outcomes after hematopoietic stem cell transplantation in childhood: a cross-sectional survey of the EBMT Pediatric Diseases Working Party.

Human reproduction (Oxford, England)·2021
Same author

Correction to: No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.

Bone marrow transplantation·2021
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
See all related articles

Area of Science:

  • Urology
  • Nephrology
  • Diagnostic Medicine

Context:

  • Asymptomatic microhematuria is a frequent reason for urological consultations.
  • Current diagnostic work-up lacks standardized guidelines from urological associations.
  • Management of asymptomatic microhematuria varies significantly among urologists.

Purpose:

  • To develop a literature-based algorithm for the diagnostic work-up of asymptomatic microhematuria.
  • To ensure the identification of serious underlying diseases.
  • To prevent unnecessary, costly, and invasive patient examinations.

Summary:

  • A comprehensive literature review was conducted to inform the development of a diagnostic algorithm for asymptomatic microhematuria.
  • The proposed algorithm aims to guide clinicians in determining the appropriate extent of patient examination.

Related Experiment Videos

  • It balances the need for thoroughness in detecting significant pathology with the avoidance of superfluous testing.

    • Impact:

    • Provides a structured approach to managing asymptomatic microhematuria.
    • Aims to improve diagnostic accuracy for potentially life-threatening conditions.
    • Offers a framework to reduce healthcare costs and patient discomfort associated with excessive testing.